Referred by Valdata Systems.
Inspection-Readable Authorization Records · MoCRA Era
Your records show the product was released.
Can they show why the safety decision was authorized?
The signature may exist. The reasoning behind it often does not.
Valdata Systems operates the validated quality environment, formulation infrastructure, and laboratory data systems that prove what happened. ComplianceWorxs preserves the authorization logic behind safety, substantiation, formulation, and disposition decisions in a form FDA cosmetics investigators, retailer auditors, and plaintiff counsel can reconstruct.
Inspection consequence
What happens when the rationale is missing.
- FDA challenges the basis for safety substantiation. The signature is real. The reasoning behind it is not on file.
- Preservative efficacy conclusion cannot be reconstructed. The PET data exists in the lab system. The conclusion drawn from the data does not.
- Prior product decisions enter retrospective review. Every release under that signature is now in scope.
- Plaintiff counsel requests the substantiation basis for a "clean" or "hypoallergenic" claim. The discovery request names the decision, not the document.
- Quality leadership reconstructs reasoning from memory. Two years after the decision. Under deposition.
30-second self-check
Is a missing authorization record important to you — or critical?
Five questions. Answer honestly. You'll see exactly where you stand under MoCRA — and why the difference between "important" and "critical" is the difference between fixing this now and discovering it during an inspection.
1 Are you the Responsible Person under MoCRA for products you place on the US market?
2 If FDA asked today, could you produce a single record showing who authorized your last product release as safe — and why — without rebuilding it from memory or email?
3 Does your team make safety, release, or disposition decisions like this most months?
4 In the last 18 months: any FDA inspection, serious adverse event, recall decision, microbial excursion, or formulation/supplier change?
5 If the person who authorized a key decision left tomorrow, would the reasoning leave with them?
Cosmetics · MoCRA exposure
MoCRA increased the burden of proving why a product safety decision was authorized — not just that documentation exists.
Whether your last regulatory cycle closed clean or MoCRA enforcement is now your top exposure — the authorization record is the artifact that turns a future investigator question into a 90-second answer instead of a reconstruction under pressure.
The cosmetics market is entering the transition pharmaceutical manufacturers went through years ago: documentation becoming enforcement-grade, substantiation expectations rising, executive accountability rising, reconstructive decision-making becoming dangerous. Valdata Systems runs the validated quality environment, formulation workflow, and laboratory data infrastructure your operation depends on. ComplianceWorxs captures the authorization logic that sits underneath the formulation, substantiation, and disposition decisions your QA team signs off on every week.
The documentation exists. The reasoning behind the authorization often does not.
The questions an investigator opens with
Safety & substantiation
- Where is the written safety substantiation supporting this product's claim of adequate substantiation under MoCRA?
- Who concluded the preservative system remained effective for the marketed shelf life — and on what data?
- Who concluded the allergen labeling was complete and accurate — and on what assessment basis?
- What data supports the stated shelf life — and who authorized the conclusion the product remains compliant through expiry?
Adverse events & contamination
- Who decided the adverse event did not require escalation — and what evidence supported that conclusion?
- Who authorized release of product from a lot with a microbial excursion — and what reasoning supported acceptable risk?
- What evidence ruled out contamination impact on adjacent product — and where is the written conclusion?
Formulation & supplier decisions
- Who approved this ingredient supplier — and what evidence supported the qualification under MoCRA expectations?
- Who authorized this formulation change — and what substantiation supported safety equivalence to the prior version?
- Who concluded this raw material remained suitable despite a supplier reformulation — and on what authority?
If FDA or plaintiff counsel challenged this decision tomorrow, could your team reconstruct the authorization basis from the record alone?
Generate your authorization record →After the snapshot
From recognition to resolution
Cosmetics MoCRA Inspection Response Record
Inspection Response Record
$497 per decision
Generate the authorization record for one of your cosmetics safety decisions in minutes — from your own inputs. The system rebuilds the reasoning, flags the reconstructability gaps before you pay, and delivers the full Inspection Defense Package: five inspection-ready deliverables built from that one decision — in the file before the question is asked.
Generate your Inspection Response Record — $497 →Ongoing Authorization Coverage
Authorization System
From $999/mo
Continuous generation of inspection-readable authorization records for recurring safety, substantiation, formulation, and disposition decisions. Unlimited authorization records, monthly inspection-exposure reviews, and the authorization layer your quality program doesn't capture.
See the Authorization System →Reference Cases
Inspection Case Files
$149 each · reference scenarios
Reference scenarios showing the decision logic regulators expect to see — safety substantiation, preservative efficacy, formulation change, adverse event disposition, supplier qualification, claims defense, and more.
View case files →Structured for reconstructability under FDA cosmetics inspection conditions and MoCRA substantiation standards. Built around real investigator questioning patterns. Designed for inspector-readable review in under 90 seconds.